Literature DB >> 21266506

Identification of S100A16 as a novel adipogenesis promoting factor in 3T3-L1 cells.

Yun Liu1, Rihua Zhang, Jing Xin, Yan Sun, Jie Li, Dong Wei, Allan Z Zhao.   

Abstract

S100A16 is a member of S100 protein super family that carries calcium-binding EF-hand motifs. Its expression is ubiquitous and elevated in various types of tumors. The functions of S100 proteins are still being defined, although many members of S100 protein family are traditionally considered as markers of tumor tissues. Using 3T3-L1 preadipocyte model, we investigated the expression and function of S100A16 during differentiation into adipocytes as well as the potential roles of S100A16 in the regulation of insulin sensitivity. We found that the expression of S100A16 was increased during differentiation and that elevation of intracellular Ca(2+) via calcium ionophores led to its nucleus exclusion. Overexpression of S100A16 in 3T3-L1 preadipocytes increased their proliferation and markedly enhanced adipogenesis but resulted in significant reduction of insulin-stimulated glucose uptake and phosphorylation of AKT. In contrast, suppression of S100A16 expression with two different types of RNA interference significantly inhibited adipogenesis and preadipocyte proliferation. Immunoprecipitation analysis revealed that S100A16 could physically interact with tumor suppressor protein p53, also a known inhibitor of adipogenesis. Overexpression or RNA interference-initiated reduction of S100A16 led to the inhibition or activation of the expression of p53-responsive genes, respectively. Interestingly, Western blot assays showed that S100A16 protein levels were markedly higher in the adipose tissues of diet-induced obese mice and the ob/ob mice than that in control lean mice. Thus, we reveal for the first time that S100A16 protein is a novel adipogenesis-promoting factor and that increased expression of S100A16 in 3T3-L1 adipocytes can have a negative impact on insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266506     DOI: 10.1210/en.2010-1059

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.

Authors:  Weidong Zhu; Yi Xue; Chao Liang; Rihua Zhang; Zhihong Zhang; Hongyan Li; Dongming Su; Xiubin Liang; Yuanyuan Zhang; Qiong Huang; Menglan Liu; Lu Li; Dong Li; Allan Z Zhao; Yun Liu
Journal:  Tumour Biol       Date:  2016-05-30

2.  Interference of S100A16 suppresses lipid accumulation and inflammation in high glucose-induced HK-2 cells.

Authors:  Lanlan Liu; Shan Lan
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

3.  S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells.

Authors:  Nariaki Tomiyama; Ryuji Ikeda; Yukihiko Nishizawa; Shogo Masuda; Yusuke Tajitsu; Yasuo Takeda
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

4.  S100A16 inhibits osteogenesis but stimulates adipogenesis.

Authors:  Dong Li; Rihua Zhang; Weidong Zhu; Yi Xue; Yuanyuan Zhang; Qiong Huang; Menglan Liu; Yun Liu
Journal:  Mol Biol Rep       Date:  2013-03-25       Impact factor: 2.316

Review 5.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

6.  S100 calcium binding proteins and ion channels.

Authors:  Anton Hermann; Rosario Donato; Thomas M Weiger; Walter J Chazin
Journal:  Front Pharmacol       Date:  2012-04-25       Impact factor: 5.810

7.  S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.

Authors:  Dipak Sapkota; Ove Bruland; Himalaya Parajuli; Tarig A Osman; Muy-Teck Teh; Anne C Johannessen; Daniela Elena Costea
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

8.  Estrogen suppresses adipogenesis by inhibiting S100A16 expression.

Authors:  Rihua Zhang; Dongming Su; Weidong Zhu; Qiong Huang; Menglan Liu; Yi Xue; Yuanyuan Zhang; Dong li; Allan Zhao; Yun Liu
Journal:  J Mol Endocrinol       Date:  2014-04-28       Impact factor: 5.098

9.  S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3β and CK1α.

Authors:  Yifei Sun; Ya Fan; Zheng Wang; Min Li; Dongming Su; Yun Liu; Xiubin Liang
Journal:  Cell Mol Life Sci       Date:  2022-03-12       Impact factor: 9.207

10.  Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer.

Authors:  Wenbin Zhou; Hong Pan; Tiansong Xia; Jinqiu Xue; Lin Cheng; Ping Fan; Yifen Zhang; Weidong Zhu; Yi Xue; Xiaoan Liu; Qiang Ding; Yun Liu; Shui Wang
Journal:  J Biomed Sci       Date:  2014-10-07       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.